Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883006 · ClinicalTrials.gov registry record · Phase 1

Regulation of Emotion, Sleep Extension, and mTBI

A Phase 1 study of Mild Traumatic Brain Injury, sponsored by Merrimack College.

Recruiting
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT06883006: Recruiting Phase 1 study of Mild Traumatic Brain Injury, sponsored by Merrimack College.

NCT06883006 is a Phase 1 study of Mild Traumatic Brain Injury that is actively recruiting participants, run by Merrimack College. The registered enrollment target is 60 participants, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883006, a Phase 1 study of Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by Merrimack College.

RECRUITING
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Concussions are incredibly common, and often result in severe and long lasting symptoms, including, but not limited to, sleep deprivation and emotion dysregulation. This study aims to demonstrate the therapeutic benefits of sleep extension (napping) on emotion regulation in individuals after they sustain a concussion. Thus, sleep extension may be a cost-effective, low risk, supplemental treatment for those with emotion dysregulation following a concussion. The main questions it aims to answer are: 1. Is a nap an effective way to improve emotion regulation in individuals with a concussion? 2. Does a nap reduce the required executive resources necessary to regulate emotions in individuals with a concussion?

Primary Outcome

After viewing each image, participants will rate the valence and arousal of the image by using the Self Assessment Manikin79 (SAM). Participants will also be asked how successful they were at following the instruction to maintain or reappraise their negative affect on a 1 to 4 scale.

Interventions

  • BEHAVIORAL Sleep Extension

Study Locations (1)

Massachusetts

  • Merrimack College - North Andover

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-02-01
Est. Completion 2027-12-31
Phase Phase 1
Merrimack College

2 total trials

What NCT06883006 shows while recruiting

NCT06883006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Sleep Extension is the first listed.

NCT06883006 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06883006 about?

NCT06883006 is a clinical study titled "Regulation of Emotion, Sleep Extension, and mTBI". Concussions are incredibly common, and often result in severe and long lasting symptoms, including, but not limited to, sleep deprivation and emotion dysregulation. This study aims to demonstrate the therapeutic benefits of sleep extension (napping) on emotion regulation in individuals after they su...

What is the current status of trial NCT06883006?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2025-02-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06883006 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT06883006?

The interventions under investigation include: Sleep Extension (BEHAVIORAL).

Who is sponsoring clinical trial NCT06883006?

This trial is sponsored by Merrimack College, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06883006 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06883006's enrollment target sits among peer trials

60 29th of 43 higher than 12 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06883006, the US trial registry maintained by the National Library of Medicine. NCT06883006 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.